About C the Signs
C the Signs is a company based in London (United Kingdom) founded in 2016 by Bhavagaya Bakshi and Miles Payling. C the Signs has raised $14.92 million across 3 funding rounds from investors including Khosla Ventures. The company has 17 employees as of April 30, 2021. C the Signs offers products and services including Cancer Prediction System. C the Signs operates in a competitive market with competitors including Atrys, Inspirata, EDP Biotech Corporation, inveox and Nanovery, among others.
- Headquarter London, United Kingdom
- Employees 17 as on 30 Apr, 2021
- Founders Bhavagaya Bakshi, Miles Payling
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name C The Signs Limited
- Date of Incorporation 22 Mar, 2017
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.92 M (USD)
in 3 rounds
-
Latest Funding Round
$8 M (USD), Series A
Jan 30, 2025
- Investors
-
Employee Count
17
as on Apr 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of C the Signs
C the Signs offers a comprehensive portfolio of products and services, including Cancer Prediction System.
AI tool that identifies cancer risks and suggests tests for early detection.
Funding Insights of C the Signs
C the Signs has successfully raised a total of $14.92M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in C the Signs
C the Signs has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Khosla Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked |
Investor details for C the Signs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by C the Signs
Investment portfolio details for C the Signs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - C the Signs
Detailed financials for C the Signs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
C The Signs Comparisons
Peer comparison for C the Signs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of C the Signs
C the Signs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atrys, Inspirata, EDP Biotech Corporation, inveox and Nanovery, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic and therapeutic services catering to cancer
|
|
| Locked | Locked | Locked |
Digital pathology solutions for cancer diagnostics are developed by Inspirata.
|
|
| Locked | Locked | Locked |
Offers online purchase of diagnostic test kits and lab appointment scheduling services.
|
|
| Locked | Locked | Locked |
Automated solutions for biopsy sample preparation in laboratories are provided.
|
|
| Locked | Locked | Locked |
Nanobots are developed for cancer diagnosis through bloodstream administration.
|
Detailed competitors of C the Signs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on C The Signs
Complete news archive for C the Signs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about C the Signs
C the Signs was founded in 2016 and raised its 1st funding round 1 year after it was founded.
C the Signs is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Bhavagaya Bakshi is the current CEO of C the Signs. They have also founded this company.
C the Signs is a funded company, having raised a total of $14.92M across 3 funding rounds to date.
As of Apr 30, 2021, the latest employee count at C the Signs is 17.
C the Signs was founded in 2016 in London, United Kingdom, within the health technology sector. A cancer prediction system is offered by the platform to analyze patient data and identify risks at early, curable stages. Services include prevention, screening, point-of-care assessment, and surveillance. Risk factors such as signs, symptoms, clinical markers, genetics, lifestyle, and environmental elements are combined in a data-driven approach to support patient identification.
C the Signs offers Cancer Prediction System.
C the Signs has 1 investor. Key investors include Khosla Ventures.